Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 2Peripheral Nervous System Diseases 1Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Lacosamide × Clear all
NCT05510856 2024-11-22

Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients

Tanta University

Phase 4 Completed
93 enrolled

Neoplasms, Peripheral Nervous System Diseases

NCT03436433 2023-04-13

Seizure Prophylaxis in Patients With Glioma or Brain Metastasis

Duke University

Phase 2 Terminated
4 enrolled 8 charts
CNS

Brain Neoplasms, Glioma

NCT01432171 2018-12-19

Lacosamide in Preventing Seizures in Participants With Malignant Glioma

M.D. Anderson Cancer Center

Phase NA Terminated
37 enrolled 11 charts
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡